Tempus AI launched its HRD-RNA algorithm, an AI-driven model for identifying Homologous Recombination Deficiency in cancer patients. The company also partnered with Median Technologies to integrate ...
ClearNote Health, a company focused on improving early detection for some of the deadliest cancers, today announced the launch of its enhanced Avantect® Pancreatic Cancer Test, which delivers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results